HK1253082A1 - 診斷乳腺癌的方法 - Google Patents
診斷乳腺癌的方法Info
- Publication number
- HK1253082A1 HK1253082A1 HK18112469.7A HK18112469A HK1253082A1 HK 1253082 A1 HK1253082 A1 HK 1253082A1 HK 18112469 A HK18112469 A HK 18112469A HK 1253082 A1 HK1253082 A1 HK 1253082A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- diagnosis
- breast cancer
- breast
- cancer
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57415—Specifically defined cancers of breast
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/14—Drugs for genital or sexual disorders; Contraceptives for lactation disorders, e.g. galactorrhoea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4703—Regulators; Modulating activity
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/705—Assays involving receptors, cell surface antigens or cell surface determinants
- G01N2333/70596—Molecules with a "CD"-designation not provided for elsewhere in G01N2333/705
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Analytical Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Urology & Nephrology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Physics & Mathematics (AREA)
- Biophysics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- General Engineering & Computer Science (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Endocrinology (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2015901895A AU2015901895A0 (en) | 2015-05-22 | Method of diagnosis |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1253082A1 true HK1253082A1 (zh) | 2019-06-06 |
Family
ID=57392279
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18112469.7A HK1253082A1 (zh) | 2015-05-22 | 2018-09-27 | 診斷乳腺癌的方法 |
Country Status (8)
Country | Link |
---|---|
US (1) | US11243205B2 (zh) |
EP (1) | EP3298145A4 (zh) |
JP (1) | JP2018522535A (zh) |
CN (1) | CN107849614A (zh) |
AU (1) | AU2016267393B2 (zh) |
CA (1) | CA2986114A1 (zh) |
HK (1) | HK1253082A1 (zh) |
WO (1) | WO2016187656A1 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2018009916A1 (en) | 2016-07-07 | 2018-01-11 | The Board Of Trustees Of The Leland Stanford Junior University | Antibody adjuvant conjugates |
WO2018144316A1 (en) * | 2017-01-31 | 2018-08-09 | The Brigham And Women's Hospital, Inc. | Alx receptor ligands define a biochemical endotype for inflammation-based diseases |
CN110458834B (zh) | 2019-02-25 | 2021-02-09 | 腾讯科技(深圳)有限公司 | 一种乳腺肿瘤图像处理系统、方法及装置 |
JP2022525594A (ja) | 2019-03-15 | 2022-05-18 | ボルト バイオセラピューティクス、インコーポレーテッド | Her2を標的とする免疫結合体 |
US20220079930A1 (en) * | 2020-02-04 | 2022-03-17 | Brain Cancer Research Institute | Therapeutic Cancer Immune Modulation by Treatment with mTOR Inhibitors |
CN115777627A (zh) * | 2022-11-17 | 2023-03-14 | 山东大学 | 一种基于噻唑橙荧光标记肿瘤细胞评价分析斑马鱼异体接种肿瘤负荷的方法及其应用 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8865653B2 (en) * | 2010-04-22 | 2014-10-21 | Institut Gustave Roussy | Method of treatment for immunogenic treatment resistant cancer |
CA2879427A1 (en) | 2012-07-20 | 2014-01-23 | La Trobe University | Method of diagnosis and treatment |
WO2014074785A1 (en) * | 2012-11-08 | 2014-05-15 | Ludwig Institute For Cancer Research Ltd. | Methods of predicting outcome and treating breast cancer |
RU2705795C2 (ru) * | 2013-08-20 | 2019-11-12 | Мерк Шарп И Доум Корп. | Лечение рака комбинацией антагониста pd-1 и динациклиба |
-
2016
- 2016-05-20 US US15/574,903 patent/US11243205B2/en active Active
- 2016-05-20 CA CA2986114A patent/CA2986114A1/en not_active Abandoned
- 2016-05-20 EP EP16798946.6A patent/EP3298145A4/en active Pending
- 2016-05-20 WO PCT/AU2016/050392 patent/WO2016187656A1/en active Application Filing
- 2016-05-20 AU AU2016267393A patent/AU2016267393B2/en active Active
- 2016-05-20 JP JP2017560764A patent/JP2018522535A/ja active Pending
- 2016-05-20 CN CN201680038752.4A patent/CN107849614A/zh active Pending
-
2018
- 2018-09-27 HK HK18112469.7A patent/HK1253082A1/zh unknown
Also Published As
Publication number | Publication date |
---|---|
EP3298145A1 (en) | 2018-03-28 |
AU2016267393B2 (en) | 2022-06-09 |
JP2018522535A (ja) | 2018-08-16 |
US20180275128A1 (en) | 2018-09-27 |
EP3298145A4 (en) | 2018-12-12 |
CN107849614A (zh) | 2018-03-27 |
US11243205B2 (en) | 2022-02-08 |
AU2016267393A1 (en) | 2017-12-07 |
CA2986114A1 (en) | 2016-12-01 |
WO2016187656A1 (en) | 2016-12-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1251409A1 (zh) | 治療癌症的方法 | |
LT3474841T (lt) | Ar+ krūties vėžio gydymo būdai | |
GB201511152D0 (en) | Method of diagnosing bladder cancer | |
PL3431609T3 (pl) | Sposób diagnozowania raka jelita grubego | |
SG11201607130RA (en) | Combination method for treatment of cancer | |
HK1253082A1 (zh) | 診斷乳腺癌的方法 | |
IL251376A0 (en) | Methods for assessing the risk of developing breast cancer | |
IL266324A (en) | Treatment of her2-positive breast cancer | |
HK1224370A1 (zh) | 用於肝癌的無創診斷的特異性生物標誌物組 | |
SG11201706544SA (en) | Breast shield | |
SG10201913528PA (en) | Methods of diagnosing cancer | |
SG11201701076TA (en) | Diagnosis of cancer | |
IL258671A (en) | A therapeutic agent for breast cancer | |
GB201408297D0 (en) | Treatment of cancer | |
IL247270B (en) | A method for detecting cancer | |
EP3389670A4 (en) | METHODS OF TREATING BREAST CANCER | |
GB201513188D0 (en) | Method of tomography | |
GB201509658D0 (en) | Method of diagnosis | |
EP3125878A4 (en) | Methods of treating breast cancer | |
GB201417456D0 (en) | Treatment of cancer | |
GB201407837D0 (en) | Methods of cancer therapy | |
GB201717509D0 (en) | Method of diagnosis | |
GB201621945D0 (en) | Method of diagnosis | |
GB201615330D0 (en) | Method of diagnosis | |
GB201512723D0 (en) | Treatment of cancer |